Prevalence of erectile dysfunction among patients with type 2 diabetes mellitus in India: a meta-analysis.

IF 2.7 Q3 ENDOCRINOLOGY & METABOLISM

Expert Review of Endocrinology & Metabolism Pub Date : 2025-02-25 DOI:10.1080/17446651.2025.2469635

Rishabh Kumar Rana, Rajan Kumar Barnwal, Anuvi Sinha, Ratnesh Sinha

{"title":"Prevalence of erectile dysfunction among patients with type 2 diabetes mellitus in India: a meta-analysis.","authors":"Rishabh Kumar Rana, Rajan Kumar Barnwal, Anuvi Sinha, Ratnesh Sinha","doi":"10.1080/17446651.2025.2469635","DOIUrl":null,"url":null,"abstract":"Background: Diabetes mellitus (DM) is an important cause of morbidity and mortality worldwide. DM patients develop both macrovascular and microvascular complications, erectile dysfunction (ED) being one of them. The risk of developing ED in DM patients as compared to those without DM is 3-4 times. Our study has reported the burden of ED in DM patients.Methods: Literature search was done by using PubMed and EMBASE databases for studies published from 1 January 2013 to 31 December 2013 by using terms such as diabetes, erectile dysfunction, and their synonyms. Pooled prevalence was calculated by using random effect model and Der Simonian-Laird method. Joanna Briggs Institute (JBI) Critical Appraisal scale for cross-sectional studies was used for assessing the study quality.Results: Five hundred and sixty-seven studies were identified, out of which 10 studies were selected. The prevalence of ED in Type 2 DM patients in India was estimated 60.57% (95% CI: 48.84-72.30%).Conclusion: Prevalence of ED in DM patients is high in India. Stigma, stress, and phobia related to ED needs to be addressed. Screening, awareness, early diagnosis, and management for ED and DM will help in improving morbidity and mortality of the nation.","PeriodicalId":12107,"journal":{"name":"Expert Review of Endocrinology & Metabolism","volume":" ","pages":"1-8"},"PeriodicalIF":2.7000,"publicationDate":"2025-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Review of Endocrinology & Metabolism","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/17446651.2025.2469635","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Diabetes mellitus (DM) is an important cause of morbidity and mortality worldwide. DM patients develop both macrovascular and microvascular complications, erectile dysfunction (ED) being one of them. The risk of developing ED in DM patients as compared to those without DM is 3-4 times. Our study has reported the burden of ED in DM patients.

Methods: Literature search was done by using PubMed and EMBASE databases for studies published from 1 January 2013 to 31 December 2013 by using terms such as diabetes, erectile dysfunction, and their synonyms. Pooled prevalence was calculated by using random effect model and Der Simonian-Laird method. Joanna Briggs Institute (JBI) Critical Appraisal scale for cross-sectional studies was used for assessing the study quality.

Results: Five hundred and sixty-seven studies were identified, out of which 10 studies were selected. The prevalence of ED in Type 2 DM patients in India was estimated 60.57% (95% CI: 48.84-72.30%).

Conclusion: Prevalence of ED in DM patients is high in India. Stigma, stress, and phobia related to ED needs to be addressed. Screening, awareness, early diagnosis, and management for ED and DM will help in improving morbidity and mortality of the nation.

查看原文本刊更多论文

印度2型糖尿病患者勃起功能障碍患病率：一项荟萃分析

背景：糖尿病（DM）是世界范围内发病率和死亡率的重要原因。糖尿病患者可并发大血管和微血管并发症，勃起功能障碍（ED）是其中之一。糖尿病患者发生ED的风险是非糖尿病患者的3-4倍。我们的研究报告了糖尿病患者ED的负担。方法：使用PubMed和EMBASE数据库检索2013年1月1日至2013年12月31日发表的文献，检索术语为糖尿病、勃起功能障碍及其同义词。采用随机效应模型和Der simonan - laird方法计算合并患病率。采用乔安娜布里格斯研究所（Joanna Briggs Institute， JBI）横断面研究关键评价量表评估研究质量。结果：共纳入567项研究，入选10项。印度2型糖尿病患者ED患病率估计为60.57% （95% CI: 48.84-72.30%）。结论：印度糖尿病患者ED患病率较高。与ED相关的耻辱、压力和恐惧需要解决。ED和DM的筛查、认识、早期诊断和管理将有助于提高全国的发病率和死亡率。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Expert Review of Endocrinology & Metabolism ENDOCRINOLOGY & METABOLISM-

CiteScore

4.80

自引率

0.00%

发文量

期刊介绍： Implicated in a plethora of regulatory dysfunctions involving growth and development, metabolism, electrolyte balances and reproduction, endocrine disruption is one of the highest priority research topics in the world. As a result, we are now in a position to better detect, characterize and overcome the damage mediated by adverse interaction with the endocrine system. Expert Review of Endocrinology and Metabolism (ISSN 1744-6651), provides extensive coverage of state-of-the-art research and clinical advancements in the field of endocrine control and metabolism, with a focus on screening, prevention, diagnostics, existing and novel therapeutics, as well as related molecular genetics, pathophysiology and epidemiology.